Logo
x

Search category

Subscribe Now

Moderna

Moderna Receives Health Canada Authorization for Updated COVID-19 Vaccine SPIKEVAX XBB.1.5

Moderna Receives Health Canada Authorization for Updated COVID-19 Vaccine SPIKEVAX XBB.1.5

  • September 13, 2023
Moderna Entered into a Research and Development Collaboration with Immatics to Develop Innovative Oncology Therapies

Moderna Entered into a Research and Development Collaboration with Immatics to Develop Innovative Oncology Therapies

  • September 11, 2023
Moderna and Merck’s mRNA-4157/V940 + Keytruda Receives PRIME Scheme Designation by the EMA for Adjuvant Treatment of High-Risk Stage III/IV Melanoma

Moderna and Merck’s mRNA-4157/V940 + Keytruda Receives PRIME Scheme Designation by the EMA for Adjuvant Treatment of High-Risk Sta...

  • April 7, 2023
PharmaShots' Key Highlights of First Quarter 2023

PharmaShots' Key Highlights of First Quarter 2023

  • April 3, 2023
Moderna and Merck Receive the US FDA’s Breakthrough Therapy Designation for mRNA-4157/V940 + Keytruda (pembrolizumab) to Treat High-Risk Melanoma

Moderna and Merck Receive the US FDA’s Breakthrough Therapy Designation for mRNA-4157/V940 + Keytruda (pembrolizumab) to Treat Hig...

  • February 23, 2023
Moderna Entered into a Collaboration and License Agreement with Cytomx to Develop mRNA-Based Conditionally Activated Therapies

Moderna Entered into a Collaboration and License Agreement with Cytomx to Develop mRNA-Based Conditionally Activated Therapies

  • January 9, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.